|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 16890 |
FusionGeneSummary for HSPB1_EGR1 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: HSPB1_EGR1 | Fusion gene ID: 16890 | Hgene | Tgene | Gene symbol | HSPB1 | EGR1 | Gene ID | 3315 | 1958 |
| Gene name | heat shock protein family B (small) member 1 | early growth response 1 | |
| Synonyms | CMT2F|HEL-S-102|HMN2B|HS.76067|HSP27|HSP28|Hsp25|SRP27 | AT225|G0S30|KROX-24|NGFI-A|TIS8|ZIF-268|ZNF225 | |
| Cytomap | 7q11.23 | 5q31.2 | |
| Type of gene | protein-coding | protein-coding | |
| Description | heat shock protein beta-128 kDa heat shock proteinepididymis secretory protein Li 102estrogen-regulated 24 kDa proteinheat shock 27 kDa proteinheat shock 27kD protein 1heat shock 27kDa protein 1stress-responsive protein 27 | early growth response protein 1EGR-1nerve growth factor-induced protein Atranscription factor ETR103transcription factor Zif268zinc finger protein 225zinc finger protein Krox-24 | |
| Modification date | 20180527 | 20180523 | |
| UniProtAcc | P04792 | P18146 | |
| Ensembl transtripts involved in fusion gene | ENST00000248553, ENST00000429938, | ENST00000239938, | |
| Fusion gene scores | * DoF score | 20 X 13 X 6=1560 | 4 X 6 X 2=48 |
| # samples | 21 | 7 | |
| ** MAII score | log2(21/1560*10)=-2.89308479608349 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(7/48*10)=0.54432051622381 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: HSPB1 [Title/Abstract] AND EGR1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | EGR1 | GO:0006366 | transcription by RNA polymerase II | 19057511 |
| Tgene | EGR1 | GO:0033233 | regulation of protein sumoylation | 19057511 |
| Tgene | EGR1 | GO:0045893 | positive regulation of transcription, DNA-templated | 12560508 |
| Tgene | EGR1 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 19057511 |
| Tgene | EGR1 | GO:0098759 | cellular response to interleukin-8 | 20363028 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | AA903814 | HSPB1 | chr7 | 75933533 | - | EGR1 | chr5 | 137802528 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 3UTR-3CDS | ENST00000248553 | ENST00000239938 | HSPB1 | chr7 | 75933533 | - | EGR1 | chr5 | 137802528 | - |
| 3UTR-3CDS | ENST00000429938 | ENST00000239938 | HSPB1 | chr7 | 75933533 | - | EGR1 | chr5 | 137802528 | - |
Top |
FusionProtFeatures for HSPB1_EGR1 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| HSPB1 | EGR1 |
| Transcriptional regulator (PubMed:20121949). Recognizesand binds to the DNA sequence 5'-GCG(T/G)GGGCG-3'(EGR-site) in thepromoter region of target genes (By similarity). Binds double-stranded target DNA, irrespective of the cytosine methylationstatus (PubMed:25258363, PubMed:25999311). Regulates thetranscription of numerous target genes, and thereby plays animportant role in regulating the response to growth factors, DNAdamage, and ischemia. Plays a role in the regulation of cellsurvival, proliferation and cell death. Activates expression ofp53/TP53 and TGFB1, and thereby helps prevent tumor formation.Required for normal progress through mitosis and normalproliferation of hepatocytes after partial hepatectomy. Mediatesresponses to ischemia and hypoxia; regulates the expression ofproteins such as IL1B and CXCL2 that are involved in inflammatoryprocesses and development of tissue damage after ischemia.Regulates biosynthesis of luteinizing hormone (LHB) in thepituitary (By similarity). {ECO:0000250|UniProtKB:P08046,ECO:0000269|PubMed:20121949, ECO:0000269|PubMed:25258363,ECO:0000269|PubMed:25999311}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for HSPB1_EGR1 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for HSPB1_EGR1 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for HSPB1_EGR1 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Hgene | HSPB1 | P04792 | DB11638 | Artenimol | Heat shock protein beta-1 | small molecule | approved|investigational |
Top |
RelatedDiseases for HSPB1_EGR1 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | HSPB1 | C2608087 | NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB | 9 | CTD_human;UNIPROT |
| Hgene | HSPB1 | C1847823 | CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F | 6 | CTD_human;ORPHANET;UNIPROT |
| Hgene | HSPB1 | C0007134 | Renal Cell Carcinoma | 1 | CTD_human |
| Hgene | HSPB1 | C0007137 | Squamous cell carcinoma | 1 | CTD_human |
| Hgene | HSPB1 | C0007194 | Hypertrophic Cardiomyopathy | 1 | CTD_human |
| Hgene | HSPB1 | C0009375 | Colonic Neoplasms | 1 | CTD_human |
| Hgene | HSPB1 | C0011616 | Contact Dermatitis | 1 | CTD_human |
| Hgene | HSPB1 | C0018801 | Heart failure | 1 | CTD_human |
| Hgene | HSPB1 | C0019693 | HIV Infections | 1 | CTD_human |
| Hgene | HSPB1 | C0020507 | Hyperplasia | 1 | CTD_human |
| Hgene | HSPB1 | C0023467 | Leukemia, Myelocytic, Acute | 1 | CTD_human |
| Hgene | HSPB1 | C0026640 | Mouth Neoplasms | 1 | CTD_human |
| Hgene | HSPB1 | C0026764 | Multiple Myeloma | 1 | CTD_human |
| Hgene | HSPB1 | C0035126 | Reperfusion Injury | 1 | CTD_human |
| Hgene | HSPB1 | C0038220 | Status Epilepticus | 1 | CTD_human |
| Hgene | HSPB1 | C0038356 | Stomach Neoplasms | 1 | CTD_human |
| Hgene | HSPB1 | C0040411 | Tongue Neoplasms | 1 | CTD_human |
| Hgene | HSPB1 | C0152013 | Adenocarcinoma of lung (disorder) | 1 | CTD_human |
| Hgene | HSPB1 | C2239176 | Liver carcinoma | 1 | CTD_human |
| Tgene | EGR1 | C0236736 | Cocaine-Related Disorders | 3 | CTD_human |
| Tgene | EGR1 | C0008372 | Intrahepatic Cholestasis | 2 | CTD_human |
| Tgene | EGR1 | C0004364 | Autoimmune Diseases | 1 | CTD_human |
| Tgene | EGR1 | C0007786 | Brain Ischemia | 1 | CTD_human |
| Tgene | EGR1 | C0008311 | Cholangitis | 1 | CTD_human |
| Tgene | EGR1 | C0008370 | Cholestasis | 1 | CTD_human |
| Tgene | EGR1 | C0020295 | Hydronephrosis | 1 | CTD_human |
| Tgene | EGR1 | C0021368 | Inflammation | 1 | CTD_human |
| Tgene | EGR1 | C0022116 | Ischemia | 1 | CTD_human |
| Tgene | EGR1 | C0025500 | Mesothelioma | 1 | CTD_human |
| Tgene | EGR1 | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
| Tgene | EGR1 | C0035126 | Reperfusion Injury | 1 | CTD_human |
| Tgene | EGR1 | C0036341 | Schizophrenia | 1 | PSYGENET |
| Tgene | EGR1 | C0242184 | Hypoxia | 1 | CTD_human |
| Tgene | EGR1 | C0853193 | Bipolar I disorder | 1 | PSYGENET |
| Tgene | EGR1 | C3495559 | Juvenile arthritis | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|